Journal of Cardiothoracic and Vascular Anesthesia
Volume 26, Issue 1 , Pages 3-10 , February 2012

The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights From 2011

  • Prakash A. Patel, MD

      Affiliations

    • Cardiovascular and Thoracic Section, Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
    • ,
  • Harish Ramakrishna, MD, FASE

      Affiliations

    • Cardiac Anesthesia, Mayo Clinic, Scottsdale, AZ
    • ,
  • Michael Andritsos, MD

      Affiliations

    • Department of Anesthesiology, The Ohio State University, Columbus, OH
    • ,
  • Tygh Wyckoff, MD

      Affiliations

    • Cardiovascular and Thoracic Section, Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
    • ,
  • Hynek Riha, MD, DEAA, FCCP

      Affiliations

    • Department of Anesthesiology and Intensive Care Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
    • ,
  • John G.T. Augoustides, MD, FASE, FAHA

      Affiliations

    • Cardiovascular and Thoracic Section, Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
    • Corresponding Author InformationAddress reprint requests to John G.T. Augoustides, MD, FASE, FAHA, Cardiothoracic Section, Anesthesiology and Critical Care, Dulles 680, HUP, 3400 Spruce Street, Philadelphia, PA 19104-4283

References 

  1. Andritsos M , Singh N , Patel P , et al.  The year in cardiothoracic and vascular anesthesia: Selected highlights from 2010 . J Cardiothorac Vasc Anesth . 2010;25:6–15
  2. Hylek EM . Therapeutic potential of oral factor Xa inhibitors . N Engl J Med . 2010;363:2559–2561
  3. EINSTEIN Investigators Bauersachs R , Berkowitz SD , et al.   Oral rivaroxaban for symptomatic venous thromboembolism . N Engl J Med . 2010;363:2499–2510
  4. Lassen MR , Gallus A , Raskop GE , et al.  Apixaban versus enoxaparin for thromboprophylaxis after hip replacement . N Engl J Med . 2010;363:2487–2498
  5. Mega JL . A new era for anticoagulation in atrial fibrillation . N Engl J Med . 2011;365:1052–1054
  6. Patel MR , Mahaffey KW , Garq J , et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation . N Engl J Med . 2011;365:883–891
  7. Granger CB , Alexander JH , McMurray JJ , et al.  Apixaban versus warfarin in patients with atrial fibrillation . N Engl J Med . 2011;365:981–992
  8. Alexander JH , Lopes RD , James S , et al.  Apixaban with antiplatelet therapy after acute coronary syndrome . N Engl J Med . 2011;365:699–708
  9. Pezborn E , Trabandt A , Selbach K , et al.  Prothrombin complex concentrate reverses the effects of high-dose rivaroxaban in rats . Pathophysiol Haemost Thromb . 2010;37:A10–OC25
  10. Eerenberg ES , Kamphuisen PW , Sijpkens MK , et al.  Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: A randomized, placebo-controlled, crossover study in healthy subjects . Circulation . 2011;124:1508–1510
  11. Perzborn E , Roehrig S , Straub A , et al.  Rivaroxaban: A new oral factor Xa inhibitor . Arterioscler Thromb Vasc Biol . 2010;30:376–381
  12. Davis EM , Packard KA , Knezevich JT , et al.  New and emerging anticoagulant therapy for atrial fibrillation and acute coronary syndrome . Pharmacotherapy . 2011;31:975–1016
  13. Friedman RJ . Novel oral anticoagulants for VTE prevention in orthopedic surgery: Overview of phase 3 trials . Orthopedics . 2011;34:795–804
  14. Hariharan S , Madabushi R . Clinical pharmacology basis of deriving dosing recommendations for dabigatran in patients with severe renal impairment . J Clin Pharmacol . 2011; [Epub ahead of print]
  15. Ganetsky M , Babu KM , Salhanick SD , et al.  Dabigatran: Review of pharmacology and management of bleeding complications of this novel oral anticoagulant . J Med Toxicol . 2011; [Epub ahead of print]
  16. Augoustides JG . Advances in anticoagulation: Focus on dabigatran, an oral direct thrombin inhibitor . J Cardiothorac Vasc Anesth . 2011;25:1208–1212
  17. Ferraris VA , Brown JR , Despotis GJ , et al.  Update to the Society of Thoracic Surgeons and Society of Cardiovascular Anesthesiologists blood conservation clinical practice guideline . Ann Thorac Surg . 2011;91:944–982
  18. Maltais S , Perrault LP , Do QB . Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: Impact of discontinuation prior to surgery . Eur J Cardiothorac Surg . 2008;34:127–131
  19. Filsoufi F , Rahmanian PB , Castillo JG , et al.  Clopidogrel treatment before coronary artery bypass graft surgery increases postoperative morbidity and blood product requirements . J Cardiothorac Vasc Anesth . 2008;22:60–66
  20. Loubser PG , Stoltz SM , Schmoker JD , et al.  Blood conservation strategies in Jehovah's Witness patients undergoing complex aortic surgery: A report of three cases . J Cardiothorac Vasc Anesth . 2003;17:528–535
  21. Martin K , Keller E , gertler R , et al.  Efficiency and safety of preoperative autologous blood donation in cardiac surgery: A matched-pair analysis in 432 patients . Eur J Cardiothorac Surg . 2010;37:1396–1401
  22. Raghunathan K , Connelly NR , Kanter G . Epsilon-aminocaproic acid and clinical value in cardiac anesthesia . J Cardiothorac Vasc Anesth . 2011;25:16–19
  23. Greff G , Stenseth R , Wahba A , et al.  Tranexamic acid reduces blood transfusions in elderly patients undergoing combined aortic valve and coronary artery bypass graft surgery: A randomized controlled trial . J Cardiothorac Vasc Anesth . 2011; [Epub ahead of print]
  24. Augoustides JG . The year in cardiothoracic and vascular anesthesia: Selected highlights from 2008 . J Cardiothorac Vasc Anesth . 2009;23:1–7
  25. Augoustides JG , Pochettino A , Ochroch EA , et al.  Renal dysfunction after thoracic aortic surgery requiring deep hypothermic circulatory arrest: Definition, incidence and clinical predictors . J Cardiothorac Vasc Anesth . 2006;20:673–677
  26. Leyvi G , Nelson O , Yedlin A , et al.  A comparison of the effect of aprotinin and epsilon-aminocaproic acid on renal function in children undergoing cardiac surgery . J Cardiothorac Vasc Anesth . 2011;25:402–406
  27. Zangrillo A , Mizzi A , Biondi-Zoccai G , et al.  Recombinant activated factor VII in cardiac surgery: A meta-analysis . J Cardiothorac Vasc Anesth . 2009;23:34–40
  28. Ponschab M , Landoni G , Biondi-Zoccai G , et al.  Recombinant activated factor VII increases stroke in cardiac surgery: A meta-analysis . J Cardiothorac Vasc Anesth . 2011;25:804–810
  29. Levi M , Levy JH , Andersen HF , et al.  Safety of recombinant factor VII in randomized clinical trials . N Engl J Med . 2010;363:1791–1800
  30. Rosenbaum L , Tomasuto P , Lipton KS , et al.  The reintroduction of nonleukoreduced blood: Would patients and clinicians agree? . Transfusion . 2011; [Epub ahead of print]
  31. Wang G , Bainbridge D , Martin J , et al.  The efficacy of an intraoperative cell saver during cardiac surgery: A meta-analysis of randomized trials . Anesth Analg . 2009;109:320–330
  32. Cheng D , Martin J , Shennib H , et al.  Endovascular aortic repair versus open surgical repair for descending thoracic aortic disease: A systematic review and meta-analysis of comparative studies . J Am Coll Cardiol . 2010;55:986–10001
  33. Cheng DC , Bainbridge D , Martin JE , et al.  Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? (A meta-analysis of randomized trials) . Anesthesiology . 2005;102:188–203
  34. Iribarne A , Easterwood R , Chan EY , et al.  The golden age of minimally invasive cardiothoracic surgery: current and future perspectives . Future Cardiol . 2011;7:333–346
  35. Brown ML , McKellar SH , Sundt TM , et al.  Ministernotomy versus conventional sternotomy for aortic valve replacement: A systematic review and meta-analysis . J Thorac Cardiovasc Surg . 2009;137:670–679
  36. El-Essawi A , Hajek T , Skorpil J , et al.  A prospective randomized multicentre clinical comparison of a minimized perfusion circuit versus conventional cardiopulmonary bypass . Eur J Cardiothorac Surg . 2010;36:91–97
  37. Augoustides JG . Update in hematology: Heparin-induced thrombocytopenia and bivalirudin . J Cardiothorac Vasc Anesth . 2011;25:371–375
  38. Mangoush O , Purkavastha S , Haj-Yahia S , et al.  Heparin-bonded circuits versus nonheparin-bonded circuits: An evaluation of their effect on clinical outcomes . Eur J Cardiothorac Surg . 2007;31:1058–1069
  39. Ranucci M , Aronson S , Dietrich W , et al.  Patient blood management during cardiac surgery: Do we have enough evidence for clinical practice? . J Thorac Cardiovasc Surg . 2011;142:e1–e32
  40. Taneja R , Fernandes P , Marwaha G , et al.  Perioperative coagulation management and blood conservation in cardiac surgery: A Canadian survey . J Cardiothorac Vasc Anesth . 2008;22:662–669
  41. Lobato RL , Despotis CJ , Levy JH , et al.  Anticoagulation management during cardiopulmonary bypass: A survey of 54 North American institutions . J Thorac Cardiovasc Surg . 2010;139:1665–1666
  42. Augoustides JG , Atluri P . Progress in mitral valve disease: Understanding the revolution . J Cardiothorac Vasc Anesth . 2009;23:916–923
  43. Alfieri O , Maisano F , De Bonis M , et al.  The double-orifice technique in mitral valve repair: A simple solution for complex problems . J Thorac Cardiovasc Surg . 2001;122:674–681
  44. Maisano F , Viganò G , Blasio A , et al.  Surgical isolated edge-to-edge mitral valve repair without annuloplasty: Clinical proof of the principle for an endovascular approach . EuroIntervention . 2006;2:181–186
  45. Feldman T , Wasserman HS , Hermann HC , et al.  Percutaneous mitral valve repair using the edge-to-edge technique: Six month results of the EVEREST phase 1 clinical trial . J Am Coll Cardiol . 2005;46:2134–2140
  46. Feldman T , Kar S , Rinaldi M , et al.  Percutaneous mitral repair with the MitraClip system: Safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge Repair Study) cohort . J Am Coll Cardiol . 2009;54:686–694
  47. Feldman T , Foster E , Glower DG , et al.  Percutaneous repair or surgery for mitral regurgitation . N Engl J Med . 2011;364:1395–1406
  48. Franzen O , Seiffert M , Baldus S , et al.  Percutaneous mitral valve repair as a bail-out strategy for patients with severe mitral regurgitation after cardiac surgery . J Thorac Cardiovasc Surg . 2011;142:227–230
  49. Skipper ER , Accola KD , Sade RM . Must surgeons tell mitral valve repair candidates about a new percutaneous repair device that is only available elsewhere? . Ann Thorac Surg . 2011;92:1163–1169
  50. Rehfeldt KH , Mauermann WJ , Burkhart  , et al.  Robot-assisted mitral valve repair . ? J Cardiothorac Vasc Anesth . 2011;25:721–730
  51. Modi P , Rodriguez E , Hargrove WC , et al.  Minimally invasive video-assisted mitral valve surgery: A 12-year, 2-center experience in 1178 patients . J Thorac Cardiovasc Surg . 2009;137:1481–1487
  52. Petracek MR , Leacche M , Solenkova N , et al.  Minimally invasive mitral valve surgery expands the surgical options for high-risk patients . Ann Surg . 2011;254:606–611
  53. Arcidi JM , Rodriguez E , Elbeery JR , et al.  Fifteen-year experience with minimally invasive approach for reoperations involving the mitral valve . J Thorac Cardiovasc Surg . 2011; [Epub ahead of print]
  54. Iribarne A , Easterwood R , Russo MJ , et al.  A minimally invasive approach is more cost-effective than a traditional sternotomy approach for mitral valve surgery . J Thorac Cardiovasc Surg . 2011;142:1507–1514
  55. Grossi EA , Loulmet DF , Schwartz CF , et al.  Minimally invasive valve surgery with antegrade perfusion strategy is not associated with increased neurologic complications . Ann Thorac Surg . 2011;92:1346–1350
  56. Fassl J , Augoustides JG . Transcatheter aortic valve implantation part 1: Development and status of the procedure . J Cardiothorac Vasc Anesth . 2010;24:498–505
  57. Fassl J , Augoustides JG . Transcatheter aortic valve implantation part 2: Anesthesia management . J Cardiothorac Vasc Anesth . 2010;24:691–699
  58. Leon MB , Smith CR , Mack M , et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery . N Engl J Med . 2010;363:1597–1607
  59. Smith CR , Leon MB , Mack MJ , et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients . N Engl J Med . 2011;364:2187–2198
  60. Guarracino F , Cabrini L , Baldassarri R , et al.  Noninvasive ventilation for awake percutaneous aortic valve implantation in high-risk respiratory patients: A case series . J Cardiothorac Vasc Anesth . 2011;25:1109–1112
  61. Dehedin B , Guinot PG , Ibrahim H , et al.  Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: An observational study of general versus local/regional anesthesia in 125 consecutive patients . J Cardiothorac Vasc Anesth . 2011;25:1036–1043
  62. Guarracino F , Covello RD , Landoni G , et al.  Anesthetic management of transcatheter aortic valve implantation with transaxillary approach . J Cardiothorac Vasc Anesth . 2011;25:437–443
  63. Holmes DR , Mack MJ . Transcatheter valve therapy: A professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons . J Am Coll Cardiol . 2011;58:445–455
  64. Vassiliades TA , Block PC , Cohn LH , et al.  The clinical development of percutaneous heart valve technology: A position statement of the Society of Thoracic Surgeons, the American Association for Thoracic Surgery, and the Society for Cardiovascular Angiography and Interventions (SCAI) endorsed by the American College of Cardiology Foundation and the American Heart Association . J Am Coll Cardiol . 2005;45:1554–1560
  65. Glauber M , Micelli A , Bevilacqua S , et al.  Minimally invasive aortic valve replacement via right anterior minithoracotomy: Early outcomes and midterm follow-up . J Thorac Cardiovasc Surg . 2011; [Epub ahead of print]
  66. Aymard T , Kadner A , Walpoth N , et al.  Clinical experience with the second-generation 3f Enable sutureless aortic valve prosthesis . J Thorac Cardiovasc Surg . 2010;140:313–316
  67. Breitenbach I , Wimmer-Greinecker G , Bockeria LA , et al.  Sutureless aortic valve replacement with the Trilogy Aortic Valve System: Multicenter experience . J Thorac Cardiovasc Surg . 2010;140:878–884
  68. ElBardissi AW , Shekar P , Couper GS , et al.  Minimally invasive aortic valve replacement in octogenerian, high-risk, trasncatheter aortic valve implantation candidates . J Thorac Cardiovasc Surg . 2011;141:328–335
  69. Moon MR . Predictive value of surgical scoring systems in determining operative risk for octogenarians undergoing aortic valve replacement . J Thorac Cardiovasc Surg . 2011;141:335–337
  70. Thomas M . The global experience with percutaneous aortic valve replacement . JACC Cardiovasc Interv . 2010;3:1103–1109
  71. Fellahi JL , Daccache G , Makroum Y , et al.  The prognostic value of the B-type natriuretic peptide after cardiac surgery: A comparative study between coronary artery bypass graft surgery and aortic valve replacement . J Cardiothorac Vasc Anesth . 2011; [Epub ahead of print]
  72. Budai A , Eikelboom JW , Mehta SR , et al.  Improving clinical outcomes by reducing bleeding in patients with non-ST elevation acute coronary syndromes . Eur Heart J . 2009;30:655–661
  73. Jolly SS , Amlani S , Hamon M , et al.  Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials . Am Heart J . 2009;157:132–140
  74. Jolly SS , Yusuf S , Cairns J , et al.  Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): A randomized, parallel group, multicentre trial . Lancet . 2011;377:1409–1420
  75. Velazquez EJ , Lee KL , Deja MA , et al.  Coronary-artery bypoass surgery in patients with left ventricular dysfunction . N Engl J Med . 2011;364:1607–1616
  76. Bonow RO , Mauer G , Lee KL , et al.  Myocardial viabilility and survival in ischemic left ventricular dysfunction . N Engl J Med . 2011;364:1617–1625
  77. Mack MJ . How should the Stich trial results affect clinical practice? . Nat Rev Cardiol . 2011;8:427–428
  78. Cohen DJ , Van Hout B , Serruys PW , et al.  Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery . N Engl J Med . 2011;364:1016–1026
  79. McKelvie RS , Moe GW , Cheung A , et al.  The 2011 Canadian Cardiovascular Society heart failure management guidelines: Focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care . Can J Cardiol . 2011;27:319–338

PII: S1053-0770(11)00708-7

doi: 10.1053/j.jvca.2011.10.005

Journal of Cardiothoracic and Vascular Anesthesia
Volume 26, Issue 1 , Pages 3-10 , February 2012

Article Tools